International TREAT

Welcome

To the international TREatment of ATopic eczema Registry Taskforce (TREAT) website

We are an international collaboration of taskforce, collecting daily practice data to investigate (cost-)effectiveness and safety of systemic immunomodulating therapies and phototherapy in patients with recalcitrant atopic eczema.

In the past we have run consensus exercises to establish our core dataset. Currently all national registries are collecting data; analyses are performed both national and international. One of our international projects is the DREAM to TREAT AD project (investigator-led, funded by Pfizer).

We are keen to extent the TREAT Registry Taskfoce family. Do get in touch directly if you would like to get involved: treatregistrytaskforce@gmail.com.

Countries

Number of patients in each national registry